Intelligence · Clinical Development
Pipeline search results
Programs matching “autologous” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 59 pipeline programs matching "autologous" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Autologous γδT cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non-Hodgkin's Lymphoma
1 trial -
Biological/Vaccine: therapeutic autologous dendritic cells.
LISATA THERAPEUTICS, INC.
Kidney Cancer
1 trial -
RESTART; Autologous Transplantation of Adult...
Disc Medicine
Patients operated with curative intend for head and neck cancer with an indication for bilateral postoperative radiotherapy, with or without chemotherapy.
1 trial -
autologous ET1402L1-CART cells
AEON Biopharma
Hepatocellular Carcinoma
1 trial -
autologous FL-33 CAR T therapy
Universal Integrated
Refractory/Relapsed Acute Myeloid Leukaemia
1 trial -
autologous cell-based delivery
Regeneron Ireland Designated Activity Company (DAC)
Hypoplastic Left Heart Syndrome
1 trial -
autologous decidual-like NK cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Abortion, Habitual
1 trial -
engineered autologous T cells
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
Senl_B19 autologous CAR-T (S1904) treatment
The First People's Hospital of Lianyungang
Relapsed Adult ALL
1 trial -
modified BEAM
The First People's Hospital of Lianyungang
Autologous Stem Cell Transplantation
1 trial -
γ-globin reactivated autologous hematopoietic stem cells
The First People's Hospital of Lianyungang
Thalassemia Major
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.